Already a member? Click here to login.
Already a member? Click here to login.
Limited supplies of Ozempic® (semaglutide) will be available in pharmacies from late next week, the Therapeutic Goods Administration (TGA) has advised.
Although supply will improve over the coming weeks, supplies will remain limited, and difficulties in sourcing the medication will likely continue.
Please note that TGA advises “that initial supplies of Ozempic will not be enough to meet demand from all patients with current valid prescriptions for type 2 diabetes nor for those taking it off-label for other conditions”.
The TGA advice includes recommendations for:
For more information, please refer to the TGA statement released on 15 February 2023.
Limited supplies of Ozempic® (semaglutide) will be available in pharmacies from late next week, the Therapeutic Goods Administration (TGA) has advised.
Although supply will improve over the coming weeks, supplies will remain limited, and difficulties in sourcing the medication will likely continue.
Please note that TGA advises “that initial supplies of Ozempic will not be enough to meet demand from all patients with current valid prescriptions for type 2 diabetes nor for those taking it off-label for other conditions”.
The TGA advice includes recommendations for:
For more information, please refer to the TGA statement released on 15 February 2023.
